IVIG may reduce seizure frequency in some children with drug-resistant epilepsy, especially those with generalized seizures.

Clinically meaningful efficacy demonstrated in the 8-week follow-up period (weeks 9-16), with a 90% median reduction in clinical seizures over baseline in weeks 9-12 and a 59% median reduction in ...

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with drug ...

A genetic predisposition for Alzheimer's disease (AD) has been associated with an increased risk of epilepsy, and vice versa, results of a large genome-wide association study (GWAS) show. "Our ...

A study published in Engineering has demonstrated that the N-glycome of serum-derived extracellular vesicles (EVs) can serve ...

Epilepsy is a common neurological disorder that affects millions of people worldwide. Characterized primarily by seizures, epilepsy can present in a variety of ways depending on the individual and the ...

The mechanisms underlying the pathogenesis of epilepsy, a neurological disorder characterized by excessive electrical activity in the brain, remain unknown. Now, using a novel radiotracer ([11 C]K-2, ...

Phase 2a follow-up period data for RAP-219 in focal onset seizures (FOS) demonstrated sustained seizure reduction, including a 90% median ...